SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-028294
Filing Date
2016-08-31
Accepted
2016-08-31 18:11:22
Documents
1
Period of Report
2016-08-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8619
  Complete submission text file 0000899243-16-028294.txt   10156
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Issuer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MEADOWLANDS PLAZA EAST RUTHERFORD NJ 07073
Business Address
Yanai Shlomo (Reporting) CIK: 0001562645 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35144 | Film No.: 161864157